N Novartis AG
| Market Cap | $297.32B |
| P/E Ratio | 21.54 |
| Forward P/E | 15.61 |
| Dividend Yield | 3.08% |
| Beta | 0.52 |
| 52W Range | $98.95 - $163.64 |
| # Hedge Funds | 5 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Hedge Fund Ownership
| Investor 5 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 0.67% | $1.24B | 9,014,641 | Reduce 14.84% |
| Kahn Brothers Group Kahn Brothers Group | 0.33% | $1.89M | 13,678 | Reduce 4.52% |
| Lee Ainslie Maverick Capital | 0.02% | $1.53M | 11,073 | Add 34.68% |
| Sarah Ketterer Causeway Capital Management | 0.00% | $266.00K | 1,935 | Reduce 5.79% |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.00% | $204.00K | 1,485 | Buy |
Frequently Asked Questions
What is NVS stock price today?
Novartis AG (NVS) is currently trading at $154.03. The stock has a 52-week range of $98.95 to $163.64 and a market capitalization of $297.32B.
Is NVS a good stock to buy in 2026?
Novartis AG has a P/E ratio of 21.5 (forward P/E: 15.6), a dividend yield of 3.08%, and 1-year performance of +41.4%. 5 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling NVS stock?
There have been 0 insider transactions for NVS in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has NVS stock performed over the past year?
Novartis AG (NVS) has returned +41.4% over the past 12 months. The stock traded between $98.95 and $163.64 during this period, and is currently at $154.03.
Which hedge funds own NVS (Novartis AG)?
5 tracked hedge funds currently hold NVS in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is NVS's market cap and valuation?
Novartis AG (NVS) has a market capitalization of $297.32B. The trailing P/E ratio is 21.5 and forward P/E is 15.6. The stock is classified in the Healthcare sector.
What is NVS's revenue and profitability?
Novartis AG reported revenue of $56.67B with net income of $13.98B and a profit margin of 0.25%. The stock has a beta of 0.52.
What sector is NVS in and who are its biggest institutional holders?
Novartis AG (NVS) operates in the Healthcare sector. It is held by 5 tracked hedge funds. See the ownership table above for the complete list.